Acadia Healthcare upgraded by KeyBanc Capital Markets with a new price target
$ACHC
Medical Specialities
Health Care
KeyBanc Capital Markets upgraded Acadia Healthcare from Sector Weight to Overweight and set a new price target of $70.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/3/2025 | $14.00 | Outperform → Market Perform | Leerink Partners |
| 12/3/2025 | $13.00 | Neutral → Underperform | BofA Securities |
| 9/10/2025 | $25.00 | Buy → Neutral | BofA Securities |
| 8/14/2025 | $26.00 | Strong Buy → Outperform | Raymond James |
| 2/28/2025 | $43.00 → $35.00 | Overweight → Equal Weight | Barclays |
| 1/7/2025 | $70.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 12/12/2024 | $45.00 → $75.00 | Hold → Buy | Deutsche Bank |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets |
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
3 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
Reaffirms Full-Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced that Debra K. Osteen, former Board member and former Chief Executive Officer of Acadia, has been appointed CEO, effective immediately. Osteen, who has also been appointed as a member of the Board, succeeds Chris Hunter, who is departing the Company and its Board of Directors. Reeve Waud, Chairman of Acadia's Board of Directors, said, "As Acadia continues to take decisive steps to optimize its growth investments and existing portfolio amidst ongoing macro headwinds facing many healthcare providers, the Board believes now is the right time to transition leadership. D
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that the Company will participate in the 44th Annual J.P. Morgan Healthcare Conference, January 12-15, 2026, in San Francisco, California. In connection with the conference, there will be an online webcast of the Company's presentation available on the Company's website starting at 5:15 p.m. Pacific Time/ 7:15 p.m. Central Time on Tuesday, January 13, 2026. The live webcast of the presentation will be available on the Company's website, www.acadiahealthcare.com, by clicking on the "Investors" link. A replay of the presentation will also be available on the Company's website for 30 days. About Acadia Acadia is a leading pr
Adjusted EBITDA Guidance Reduced by $49M and EPS by $0.41, Driven Entirely by an Increase in Professional and General Liability Expenses Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced an update to its professional and general liability ("PLGL") reserves, following its annual, third-party actuarial review of anticipated PLGL costs. This update reflects higher expected expenses associated primarily with patient-related litigation. As a result, the Company now expects full-year 2025 Adjusted EBITDA in the range of $601 million to $611 million, compared to its prior guidance of $650 million to $660 million, reflecting an incremental $49 million of PL
Leerink Partners downgraded Acadia Healthcare from Outperform to Market Perform and set a new price target of $14.00
BofA Securities downgraded Acadia Healthcare from Neutral to Underperform and set a new price target of $13.00
BofA Securities downgraded Acadia Healthcare from Buy to Neutral and set a new price target of $25.00
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
Third Quarter Revenue of $851.6 Million Increased 4.4% Year-Over-Year Lowering Full-Year Outlook Acadia Taking Decisive Actions to Optimize Portfolio in Order to Reduce Capital Expenditures and Increase Free Cash Flow Generation Referral Initiatives Drive Accelerating Admissions Growth Todd Young joined as CFO on October 27; Announces departure of COO Dr. Nasser Khan Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Results Revenue totaled $851.6 million, an increase of 4.4% over the third quarter of 2024 Same facility revenue increased 3.7% compared with th
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its third quarter 2025 results on Wednesday, November 5, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, November 6, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of June 30, 2025, Acadia operated a network of 274 behavioral healthcare facilit
Provides Updated Guidance for 2025; Announces Chief Financial Officer Transition Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenue totaled $869.2 million, an increase of 9.2% over the second quarter of 2024 Same facility revenue increased 9.5% compared with the second quarter of 2024, including an increase in revenue per patient day of 7.5% and an increase in patient days of 1.8% Net income attributable to Acadia totaled $30.1 million, or $0.33 per diluted share Adjusted income attributable to Acadia totaled $74.8 million, or $0.83 per
Reaffirms Full-Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced that Debra K. Osteen, former Board member and former Chief Executive Officer of Acadia, has been appointed CEO, effective immediately. Osteen, who has also been appointed as a member of the Board, succeeds Chris Hunter, who is departing the Company and its Board of Directors. Reeve Waud, Chairman of Acadia's Board of Directors, said, "As Acadia continues to take decisive steps to optimize its growth investments and existing portfolio amidst ongoing macro headwinds facing many healthcare providers, the Board believes now is the right time to transition leadership. D
Young Brings 25 Years of Financial and Healthcare Industry Experience Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia" or the "Company") today announced the appointment of Todd Young as Chief Financial Officer, effective October 27, 2025. Tim Sides, who has been serving as the Company's interim CFO since August 2025, will resume his role as Senior Vice President, Operations Finance. Young brings to Acadia nearly a decade of executive-level finance experience at publicly traded healthcare companies. He most recently served as CFO at Elanco Animal Health ("Elanco") where he joined in 2018 as Elanco was separating from Eli Lilly and Company. Young developed a robust finance organiza
NEW YORK, Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Uber Technologies Inc. (NYSE:UBER) will replace Charter Communications Inc. (NASD: CHTR) in the S&P 100. Charter Communications will remain in the S&P 500.AppLovin Corp. (NASD: APP), Robinhood Markets Inc. (NASD: H